|
FAM160A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.97689999820372E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.16429999980272E-08 |
| Normal-vs-Stage2 |
4.380100000001E-05 |
| Normal-vs-Stage3 |
1.192110E-02 |
| Normal-vs-Stage4 |
1.363820E-03 |
| Stage1-vs-Stage2 |
9.255600E-01 |
| Stage1-vs-Stage3 |
6.897200E-01 |
| Stage1-vs-Stage4 |
9.380200E-01 |
| Stage2-vs-Stage3 |
7.675800E-01 |
| Stage2-vs-Stage4 |
8.881800E-01 |
| Stage3-vs-Stage4 |
7.759400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.61180000352235E-08 |
| Normal-vs-AfricanAmerican |
3.21260000002432E-06 |
| Normal-vs-Asian |
1.537410E-03 |
| Caucasian-vs-AfricanAmerican |
8.805200E-01 |
| Caucasian-vs-Asian |
6.573400E-01 |
| AfricanAmerican-vs-Asian |
6.357400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40410025220683E-10 |
| Normal-vs-Female |
1.435890E-02 |
| Male-vs-Female |
1.421360E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.62079999999465E-05 |
| Normal-vs-Extreme_Weight |
1.26429999802724E-09 |
| Normal-vs-Obese |
2.395900E-04 |
| Normal-vs-Extreme_Obese |
5.603500E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.823800E-01 |
| Normal_Weight-vs-Obese |
3.920200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.215200E-01 |
| Extreme_Weight-vs-Obese |
3.326200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.530600E-01 |
| Obese-vs-Extreme_Obese |
6.432600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.862780E-01 |
| Normal-vs-Age(41-60Yrs) |
4.10730000011128E-07 |
| Normal-vs-Age(61-80Yrs) |
3.47530000333052E-08 |
| Normal-vs-Age(81-100Yrs) |
2.50440000004737E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.988400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.443000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.917440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.598200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.307030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.609200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.28000054999688E-10 |
| Normal-VS-Type2 PRCC |
3.79090000002247E-06 |
| Normal-VS-KIRP CIMP |
8.376600E-01 |
| Normal-VS-Unclassified PRCC |
2.944200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.381000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.583800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.709600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.530400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.509200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.093600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08539954801756E-10 |
| Normal-vs-N1 |
1.252320E-02 |
| Normal-vs-N2 |
4.395700E-02 |
| N0-vs-N1 |
2.486200E-01 |
| N0-vs-N2 |
7.031000E-01 |
| N1-vs-N2 |
9.305400E-01 |
|
|
